# COMMERCIAL DEVELOPMENT COMPANY PLC Financial Summary

Canonical URL: https://pal.lk/updates/comd-financial-summary
Symbol: COMD.N0000
Company: COMMERCIAL DEVELOPMENT COMPANY PLC
Sector: Commercial & Professional Services
Published: 2026-07-28T11:22:45Z
Last updated: 2026-07-28T11:22:44Z

# Commercial Development Company PLC Financial Summary and Investment Analysis

## Executive Overview
Commercial Development Company PLC (CDC) is a publicly listed property and facility management company, operating as a 90%-owned subsidiary of Commercial Bank of Ceylon PLC. CDC's core mandate is to provide exclusive support services to its parent bank, including premises renting, staff outsourcing, vehicle hiring, and utility services. 

For the periods reviewed, CDC displayed steady top-line revenue growth fueled by revised rental terms, expanded outsourced staff cadres, and the introduction of a new CCTV maintenance business line in Q3 2025. However, while revenue grew, net profitability experienced volatility. The statutory net profit in CY2025 declined compared to CY2024 due to substantially lower fair-value gains on investment properties. In H1 2026, despite a 21.2% YoY increase in revenue, net profit contracted by 18.7% YoY due to steep cost escalations from structural repairs, air quality improvements, CCTV rollout expenses, and salary revisions. The company remains highly liquid and virtually debt-free, positioned as a stable, dividend-paying anchor within its parent company's ecosystem.

**Key periods covered:** Q1 2024 to Q2 2026 (Calendar Years 2024, 2025, and H1 2026).

## Financial Performance

### Revenue and Profitability Trends

| Period | Revenue (Rs. '000) | Gross Profit (Rs. '000) | Net Profit (Rs. '000) | GP Margin | NP Margin |
|--------|--------------------|-------------------------|-----------------------|-----------|-----------|
| Q1 2024| 175,326 | 70,391 | 60,505 | 40.1% | 34.5% |
| Q2 2024| 174,445 | 53,712 | 50,743 | 30.8% | 29.1% |
| Q3 2024| 180,774 | 88,967 | 71,144 | 49.2% | 39.4% |
| Q4 2024| 177,715 | 81,191 | 400,231 | 45.7% | 225.2%*|
| Q1 2025| 178,937 | 74,572 | 59,046 | 41.7% | 33.0% |
| Q2 2025| 184,760 | 74,978 | 59,515 | 40.6% | 32.2% |
| Q3 2025| 243,391 | 139,153 | 100,050 | 57.2% | 41.1% |
| Q4 2025| 208,821 | 86,494 | 202,924 | 41.4% | 97.2%* |
| Q1 2026| 213,201 | 64,806 | 48,733 | 30.4% | 22.9% |
| Q2 2026| 227,574 | 67,273 | 47,670 | 29.6% | 20.9% |
*\*Net Profit Margins in Q4 are heavily distorted by annual fair value gains on investment properties.*

**Analysis:**
*   **Revenue Growth:** Top-line revenue increased consistently, culminating in a 15.2% YoY growth in CY2025 (Rs. 815.9 Mn) and a 21.2% YoY growth in H1 2026. This was driven by revised rental lease terms starting January 2025, expansion of the outsourced workforce, and the addition of CCTV maintenance operations.
*   **Gross Profit Margins:** GP margins experienced a notable squeeze in H1 2026, dropping to ~30% from a historical average of ~40-45%. Management attributes this to heavy progress payments for an Indoor Air Quality (IAQ) improvement project, structural repairs (waterproofing and cracking) at the Commercial House building, and rising municipal rates.
*   **Net Profit:** Net profit is structurally dependent on Q4 fair value gains on property. Excluding fair value gains, core operating profit actually improved by 27.6% in CY2025. However, in H1 2026, core net profit dropped 18.7% YoY due to the aforementioned repair costs and declining interest income from fixed deposits as market rates normalized.

## Balance Sheet Analysis

CDC boasts a fortress balance sheet characterized by high-value real estate, significant cash equivalents, and virtually zero structural debt.

| Balance Sheet Item | End CY2024 (Rs. '000) | End CY2025 (Rs. '000) | Q2 2026 (Rs. '000) |
|--------------------|-----------------------|-----------------------|--------------------|
| **Total Assets** | 4,909,396 | 5,315,426 | 5,372,620 |
| Investment Property| 3,608,451 | 3,754,673 | 3,754,673 |
| Current Assets | 1,247,918 | 1,182,293 | 893,192 |
| **Total Liabilities**| 786,378 | 860,161 | 868,951 |
| Current Liabilities| 80,081 | 105,476 | 93,757 |
| **Total Equity** | 4,123,018 | 4,455,266 | 4,503,669 |

**Analysis:**
*   **Liquidity:** The current ratio stands at a highly robust 9.5x as of Q2 2026 (down slightly from 11.2x at End 2025). The company holds massive short-term financial investments (Rs. 615 Mn in Fixed Deposits) and cash (Rs. 52.7 Mn).
*   **Solvency:** CDC carries no conventional bank loans or debt securities. Its liabilities primarily consist of deferred taxation (Rs. 542 Mn), employee benefits, and minor lease creditors (Rs. 46 Mn). The Debt-to-Equity ratio is functionally 0%.
*   **Asset Mix:** Approximately 70% of the total asset base is tied to Investment Properties (Commercial House in Colombo, Tangalle, and Negombo properties).

## Cash Flow Analysis

| Cash Flow Summary | CY 2024 (Rs. '000) | CY 2025 (Rs. '000) | H1 2026 (Rs. '000) |
|-------------------|--------------------|--------------------|--------------------|
| Operating Cash Flow| 172,190 | 168,900 | 2,278 |
| Investing Cash Flow| (33,115) | (104,051) | (5,984) |
| Financing Cash Flow| (119,196) | (97,512) | (73,127) |
| **Net Change in Cash**| 19,879 | (32,663) | (76,833) |

**Analysis:**
*   **Operating Cash Flow:** Remained steady in 2024 and 2025 but collapsed to near zero (Rs. 2.27 Mn) in H1 2026. This severe contraction was driven by a sharp increase in trade receivables (up Rs. 99.5 Mn) and heavy tax payments (Rs. 58.5 Mn). 
*   **Investing Cash Flow:** Driven by periodic upgrades to property, plant, and equipment, and the rotation of massive fixed deposit investments.
*   **Financing Cash Flow:** Consists almost entirely of dividend payouts (Rs. 83.4 Mn in 2025) and minor lease liability settlements. Dividend sustainability remains strong given the accumulated retained earnings (Rs. 1.45 Bn).

## Key Financial Ratios and Growth Indicators

| Metric | CY 2024 | CY 2025 | H1 2026 (Annualized/Spot) |
|--------|---------|---------|---------------------------|
| **Return on Equity (ROE)** | 15.05% | 9.83% | ~4.3% (Est.) |
| **Return on Assets (ROA)** | 12.62% | 8.25% | ~3.6% (Est.) |
| **Earnings Per Share (EPS)**| Rs. 48.55 | Rs. 35.13 | Rs. 8.03 (H1 only) |
| **Net Asset Value (NAV)** | Rs. 343.58 | Rs. 371.27 | Rs. 375.31 |
| **Dividend Yield** | 4.96% | 2.52% | N/A |
| **Dividend Payout Ratio** | 14.42% | 19.93% | N/A |

*   **Growth Indicators:** The company achieved a 15.2% YoY revenue growth in 2025 and 21.2% in H1 2026. However, EPS dropped materially due to fluctuating non-cash fair value property gains and recent core margin compression. 
*   **Strategic Expansions:** Successful roll-out of CCTV installation and maintenance for Commercial Bank branches, diversifying the historically rigid service portfolio.

## Economic and Market Context
*   **Macro Environment:** Sri Lanka’s domestic economy has moved onto a recovery trajectory with stabilized inflation and real GDP growth. 
*   **Interest Rate Impact:** As domestic market interest rates have declined, CDC’s finance income—generated from its massive fixed deposit reserves (over Rs. 930 Mn at end-2025)—dropped by 12.3% YoY in 2025 and continued to fall in 2026.
*   **Market Position:** CDC operates in a completely captive market, servicing only its parent company, Commercial Bank of Ceylon PLC. While this shields it from open-market competitive pressures, it inherently caps exponential growth.

## Future Potential and Outlook
*   **Strategic Trajectory:** Management targets ~10% YoY growth through operational initiatives. For 2026, the company aims to sustain 13% revenue growth and maintain operating margins above 65% (excluding direct costs). 
*   **Infrastructure:** Significant remedial infrastructure works at Commercial House (e.g., precast fascia panels, HVAC upgrades) will secure the long-term value of the core asset but will remain a drag on cash flow and gross margins throughout 2026.
*   **Digital & Service Enhancement:** A scheduled vehicle fleet upgrade and expanded AC/CCTV servicing capabilities indicate a continued deepening of the service integration with the parent bank.

## Risks and Challenges
*   **Client Concentration Risk:** 100% of core business relies on Commercial Bank of Ceylon PLC. The lack of customer diversification makes CDC entirely dependent on the parent's operational roadmap.
*   **Margin Squeeze from Aging Assets:** High maintenance costs, regulatory safety compliance, and structural repairs on aging real estate (Commercial House) are aggressively eroding gross margins.
*   **Regulatory Constraints:** CDC is bound by a strict, approved regulatory mandate, severely limiting its ability to seek external clientele or pivot to higher-margin business models outside the parent's ecosystem.
*   **Mitigation:** The company counters these risks with zero debt, vast liquidity reserves, structured enterprise risk management (ERM) frameworks, and long-term secure lease agreements with its parent.

## Shareholder and Corporate Information
*   **Shareholding Structure:** Commercial Bank of Ceylon PLC owns 90% (10,800,000 shares). The public float is exactly 10%, complying with the minimum continuous listing requirements of the CSE Diri Savi Board.
*   **Stock Performance:** The stock has seen massive price appreciation, soaring from Rs. 141.00 at the end of 2024 to Rs. 278.00 by the end of 2025, and peaking at Rs. 305.00 by Q2 2026. 
*   **Dividends:** A steady dividend payer, offering Rs. 7.00 per share in 2024 and 2025. 

## Investment Decision Indicators

**Strengths:**
*   Guaranteed, low-risk revenue stream backed by Sri Lanka's largest private bank.
*   Fortress balance sheet with zero structural debt and immense cash/FD liquidity.
*   High asset backing with a growing Net Asset Value per share (Rs. 375.31).
*   Consistent dividend payout history.

**Weaknesses:**
*   Total reliance on a single customer (100% concentration risk).
*   Recent margin compression due to unavoidable capital/maintenance expenditures on aging infrastructure.
*   Declining finance income due to falling macroeconomic interest rates.
*   Net profit heavily skewed by non-cash property revaluations, masking tighter operating cash flows.

**Opportunities and Threats:**
*   *Opportunities:* Deepening service lines (like CCTV and IT infrastructure maintenance) to capture more of the parent bank’s outsourced operational expenditure.
*   *Threats:* Continued cost escalations in building maintenance, utility rates, and payroll could further squeeze net margins in late 2026.

**Overall Assessment:** 
*   **Rationale for Hold/Buy/Sell:** For investors prioritizing capital preservation and steady asset backing, CDC offers a bond-like equity profile due to its captive revenue and zero debt. However, at the current elevated share price (Rs. 305.00 in Q2 2026, up from Rs. 141.00), the P/E ratio has expanded significantly while core operating margins and operating cash flows have recently contracted. The stock trades relatively close to its Net Asset Value (Rs. 375.31), meaning the deep discount to book value that previously existed has narrowed. Investors must weigh the safety of the Commercial Bank backing against the lack of high-growth potential and current margin pressures.